Amit Sharon - Gauzy Vice Development
| GAUZ Stock | 9.45 1.00 9.57% |
Executive
Amit Sharon is Vice Development of Gauzy Ltd Ordinary
| Address | 14 Hathiya Street, Tel Aviv, Israel, 6816914 |
| Phone | 972 72 250 0385 |
| Web | https://www.gauzy.com |
Gauzy Management Efficiency
The company has return on total asset (ROA) of (0.145) % which means that it has lost $0.145 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.2232) %, meaning that it created substantial loss on money invested by shareholders. Gauzy's management efficiency ratios could be used to measure how well Gauzy manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.57 in 2025. Return On Capital Employed is likely to drop to -0.4 in 2025. At this time, Gauzy's Non Currrent Assets Other are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.45 in 2025, whereas Total Assets are likely to drop slightly above 92.5 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Charisse Hughes | Kellanova | 53 | |
| James Myers | Spyre Therapeutics | N/A | |
| Eric McIntyre | Spyre Therapeutics | N/A | |
| MPH MD | Ardelyx | 61 | |
| James JD | Spyre Therapeutics | 52 | |
| Melissa Cooper | Spyre Therapeutics | N/A | |
| Tiffany BSc | Abcellera Biologics | N/A | |
| JD Esq | Acumen Pharmaceuticals | 54 | |
| Andy Clark | Abcellera Biologics | N/A | |
| Robert Felsch | Ardelyx | N/A | |
| Michael Bridgford | Bridgford Foods | 43 | |
| Bob McCowan | Regeneron Pharmaceuticals | N/A | |
| Kordell Beckham | Kellanova | N/A | |
| Doug Vandevelde | Kellanova | 58 | |
| MiRa Huyghe | Spyre Therapeutics | N/A | |
| CFE CPA | Spyre Therapeutics | N/A | |
| Lauren Beck | Kellanova | N/A | |
| Kelly Boothe | Spyre Therapeutics | N/A | |
| Kathleen BA | Abcellera Biologics | N/A | |
| Josephine Hellschlienger | Abcellera Biologics | N/A | |
| Chris Cole | Bridgford Foods | N/A | |
Management Performance
| Return On Equity | -4.22 | ||||
| Return On Asset | -0.14 |
Gauzy Ordinary Leadership Team
Elected by the shareholders, the Gauzy's board of directors comprises two types of representatives: Gauzy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gauzy. The board's role is to monitor Gauzy's management team and ensure that shareholders' interests are well served. Gauzy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gauzy's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Meir Peleg, Chief Officer | ||
| Hadas Mahler, Chief Officer | ||
| Eyal Peso, Chairman CoFounder | ||
| Francois Jessey, Executive ASIA | ||
| Adrian Lofer, CoFounder CTO | ||
| David Berre, Executive Center | ||
| Brittany Swisa, Chief Officer | ||
| Dudi Baruch, Chief Officer | ||
| Jerome Monvaillier, EVP MD | ||
| Amit Sharon, Vice Development |
Gauzy Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Gauzy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.22 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.87) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 202.14 M | ||||
| Shares Outstanding | 18.68 M | ||||
| Shares Owned By Insiders | 15.69 % | ||||
| Shares Owned By Institutions | 42.01 % | ||||
| Number Of Shares Shorted | 120.22 K | ||||
| Price To Book | 2.84 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gauzy Stock Analysis
When running Gauzy's price analysis, check to measure Gauzy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gauzy is operating at the current time. Most of Gauzy's value examination focuses on studying past and present price action to predict the probability of Gauzy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gauzy's price. Additionally, you may evaluate how the addition of Gauzy to your portfolios can decrease your overall portfolio volatility.